Matthew I. Milowsky

University of North Carolina at Chapel Hill

Also affiliated with UNC Lineberger Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database—UNC GOLD

UNC Libraries(2020)10.17615/wp7f-0437

Top 100%

0DataRank

Top 100%0 citations

Matthew E. Nielsen, Raj S. Pruthi, Eric Wallen, Chaochen You, Sarah Gallagher +13 more

Papers

Driven by 45 papers — median percentile 0. Top paper: “Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma”.

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine(2021)10.1056/nejmoa2034442

N/A

7.0DataRank · unranked

1043 citations

J. Alfred Witjes, Jürgen E. Gschwend, Michael Schenker, Begoña P. Valderrama, Yoshihiko Tomita +24 more

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02887

N/A

4.4DataRank · unranked

181 citations

Matthew I. Milowsky, Daniel P. Petrylak, Christopher Hoimes, Thomas W. Flaig, Nataliya Mar +20 more

A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2409

N/A

2.8DataRank · unranked

92 citations

Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, Seth P. Lerner, M. Scott Lucia +12 more

Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma

JAMA Oncology(2021)10.1001/jamaoncol.2021.3441

N/A

1.6DataRank · unranked

45 citations

Paul Frankel, Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh +15 more

Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)

European Urology(2023)10.1016/j.eururo.2023.06.014

N/A

0.650DataRank · unranked

20 citations

Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, M. Scott Lucia, David J. McConkey +12 more

Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective Study

The Journal of Urology(2024)10.1097/ju.0000000000004023

N/A

0.241DataRank · unranked

4 citations

Kathryn H. Gessner, Allison M. Deal, Hillary Heiling, Shannon Myers, Mathew Raynor +11 more

Trends in Stage-Specific Incidence Rates for Urothelial Carcinoma of the Bladder in the United States: 1988 to 2006

UNC Libraries(2020)10.17615/kc17-xf64

N/A

0DataRank · unranked

0 citations

Matthew I. Milowsky, Angela B. Smith, William Y. Kim, Seth Tyree, Tzy Mey Kuo +4 more

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer

UNC Libraries(2020)10.17615/41rk-2070

N/A

0DataRank · unranked

0 citations

Matthew D. Galsky, Iain J. Webb, Jesika Petruck, Michael J. Morris, Robert Dreicer +7 more

Arrays of high-aspect ratio microchannels for high-throughput isolation of circulating tumor cells (CTCs)

UNC Libraries(2020)10.17615/zm96-j620

N/A

0DataRank · unranked

0 citations

Steven A. Soper, Hong Wang, Young E. Whang, Mateusz L. Hupert, Małgorzata A. Witek +3 more

Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings

UNC Libraries(2020)10.17615/1nhx-4121

N/A

0DataRank · unranked

0 citations

Tracy L. Rose, Ronald C. Chen, Eric Wallen, Matthew E. Nielsen, Michael E. Woods +11 more

Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database—UNC GOLD

UNC Libraries(2020)10.17615/wp7f-0437

Top 100%

0DataRank

Top 100%0 citations

Matthew E. Nielsen, Raj S. Pruthi, Eric Wallen, Chaochen You, Sarah Gallagher +13 more

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Cancer(2021)10.1002/cncr.34057

N/A

0DataRank · unranked

86 citations

Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam +31 more

Entinostat induces antitumor immune responses through immune editing of tumor neoantigens

Journal of Clinical Investigation(2021)10.1172/jci138560

N/A

0DataRank · unranked

83 citations

Mi Zhou, Bhavani Krishnan, Takanobu Utsumi, Ujjawal Manocha, Kyle G. Stewart +12 more

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0205

N/A

0DataRank · unranked

53 citations

Kyle R. Roell, Markia A. Smith, Xuezheng Sun, Erin L. Kirk, Katherine A. Hoadley +15 more

Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.03.007

N/A

0DataRank · unranked

22 citations

Yuan Liu, Matthew I. Milowsky, Jason A. Efstathiou, Ashesh B. Jani, Benjamin W. Fischer‐Valuck +2 more

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

European Urology Open Science(2021)10.1016/j.euros.2021.09.015

N/A

0DataRank · unranked

19 citations

Emmanuel S. Antonarakis, Tina Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan +22 more

Overall Survival of Biopsy-confirmed T1B and T2A Kidney Cancers Managed With Observation: Prognostic Value of Tumor Histology

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2020.12.006

N/A

0DataRank · unranked

1 citations

Nermarie Velázquez, Audrey Renson, Hung‐Jui Tan, Tracy L. Rose, Chelsea K. Osterman +6 more

Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4504

N/A

0DataRank · unranked

42 citations

Matthew I. Milowsky, Peter H. O’Donnell, Ajjai Alva, Marisa Kollmeier, Tracy L. Rose +15 more

Sapanisertib, a dual mTORC1/2 inhibitor, for TSC1- or TSC2-mutated metastatic urothelial carcinoma (mUC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.431

N/A

0DataRank · unranked

10 citations

Matthew I. Milowsky, Noah M. Hahn, David J. Kwiatkowski, Alicia K. Morgans, Nancy B. Davis +10 more

Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.396

N/A

0DataRank · unranked

8 citations

Michael R. Harrison, Allison M. Deal, Chelsea K. Osterman, Sundhar Ramalingam, Young E. Whang +12 more

A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4507

N/A

0DataRank · unranked

1 citations

Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh, Yung Lyou +15 more

Non-oncology clinical trial engagement in a nationally representative sample: Identification of motivators and barriers

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106715

N/A

0DataRank · unranked

10 citations

Richard S. Matulewicz, Ramsankar Basak, Donna A. Culton, Kimberly N. Weaver, Kristalyn K. Gallagher +5 more

History of the Relationship Between Smoking and Bladder Cancer: A Public Health Perspective

Urology(2022)10.1016/j.urology.2022.08.007

N/A

0DataRank · unranked

3 citations

Richard S. Matulewicz, Elizabeth Moreton, Kimberly A. Shoenbill, Matthew I. Milowsky, Tracy L. Rose +4 more

Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer Surveillance

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.04.006

N/A

0DataRank · unranked

2 citations

Xi Zhou, Christopher D. Baggett, Marc A. Bjurlin, Ronald C. Chen, Stephen B. Riggs +5 more

SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.536

N/A

0DataRank · unranked

5 citations

Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, M. Scott Lucia, David J. McConkey +12 more

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad155

N/A

0DataRank · unranked

56 citations

Amin H. Nassar, Gregory R. Pond, Tony Zhuang, Viraj A. Master, Bassel Nazha +50 more

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0602

N/A

0DataRank · unranked

19 citations

David J. McConkey, Catherine M. Tangen, Joshua J. Meeks, Thomas W. Flaig, Xing Hua +12 more

Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications

Cancer Treatment and Research Communications(2023)10.1016/j.ctarc.2023.100779

N/A

0DataRank · unranked

9 citations

Kathryn H. Gessner, Alysen Demzik, Elizabeth Moreton, William Y. Kim, Sara E. Wobker +4 more

Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot

Current Problems in Cancer(2023)10.1016/j.currproblcancer.2023.100958

N/A

0DataRank · unranked

2 citations

Gabrielle Nortey, Richard S. Matulewicz, Ramsankar Basak, Donna A. Culton, Kimberly N. Weaver +6 more

Study EV-103 dose escalation/cohort A: Long-term outcome of enfortumab vedotin + pembrolizumab in first-line (1L) cisplatin-ineligible locally advanced or metastatic urothelial carcinoma (la/mUC) with nearly 4 years of follow-up.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4505

N/A

0DataRank · unranked

21 citations

Jonathan E. Rosenberg, Rana R. McKay, Thomas W. Flaig, Daniel P. Petrylak, Christopher Hoimes +14 more

FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression

Journal of Clinical Investigation(2024)10.1172/jci169241

N/A

0DataRank · unranked

30 citations

Takanobu Utsumi, Michela Ranieri, Xingnan Zheng, Mi Zhou, Luiza Doro Pereira +20 more

Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer

Nature Communications(2024)10.1038/s41467-024-48480-1

N/A

0DataRank · unranked

29 citations

Mi Zhou, Jin Seok Lee, Steven Vensko, Mark G. Woodcock, Hsing‐Hui Wang +14 more

Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0803

N/A

0DataRank · unranked

10 citations

Olivia Bobek, Irenaeus C.C. Chan, Brian C. Miller, David W. Hillman, Glenn Heller +8 more

Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0352

N/A

0DataRank · unranked

6 citations

Kathryn H. Gessner, Krishna Kanchi, Jay A. Moore, Zoë Fleischmann, Dexter X. Jin +12 more

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

UNC Libraries(2024)10.17615/6gs3-hm85

N/A

0DataRank · unranked

0 citations

Irina Ostrovnaya, Matthew I. Milowsky, Jonathan E. Rosenberg, Wassim Abida, Dean F. Bajorin +6 more

Patterns of chemotherapy administration in bladder preservation therapy (BPT) for muscle-invasive bladder cancer (MIBC).

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2024)10.17615/7y09-8d51

N/A

0DataRank · unranked

0 citations

Evan Y. Yu, Lauren C. Harshman, Nielsen, Matthew Edward, Yu‐Ning Wong, Andrew Z. Wang +14 more

Poor prognosis among radiation associated bladder cancer is defined by clinicogenomic features

UNC Libraries(2024)10.17615/aav1-t330

N/A

0DataRank · unranked

0 citations

Garrett M. Frampton, Jay A. Moore, N. Ari Wijetunga, Kathryn H. Gessner, Jeffrey S. Damrauer +12 more

Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot

UNC Libraries(2025)10.17615/87ff-he24

N/A

0DataRank · unranked

0 citations

Hung‐Jui Tan, Tracy L. Rose, Richard S. Matulewicz, Ramsankar Basak, Gabrielle Nortey +6 more

Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.02.014

N/A

0DataRank · unranked

46 citations

Christopher Tully, Emily C. Zabor, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr +8 more

Impact of Renal Mass Biopsy on Decision-Making Experience for Clinical T1 Renal Masses

The Journal of Urology(2025)10.1097/ju.0000000000004832

N/A

0DataRank · unranked

0 citations

Allison M. Deal, Amir Feinberg, Shannon Myers, Katherine E. Poulos, Hillary Heiling +13 more

A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer

Cancer(2020)10.1002/cncr.33067

N/A

0DataRank · unranked

35 citations

Michael R. Harrison, Peter H. O’Donnell, Ajjai Alva, Noah M. Hahn, Leonard J. Appleman +17 more

Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell–Renal-Cell-Carcinoma: Proof-of-Concept Study

UNC Libraries(2020)10.17615/1h7z-hv37

N/A

0DataRank · unranked

5 citations

Michael Woods, Sheng‐Che Hung, Dinggang Shen, Qingbo Yin, Julia R. Fielding +7 more

Association of molecular subtypes with pathologic response in a phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy (NAC) for localized, muscle-invasive bladder cancer (SWOG S1314; NCT02177695).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5028

N/A

0DataRank · unranked

4 citations

David J. McConkey, Catherine M. Tangen, Joshua J. Meeks, Thomas W. Flaig, Xing Hua +11 more

Functional outcomes of older adults treated with radical cystectomy for muscle-invasive bladder cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17010

N/A

0DataRank · unranked

0 citations

Allison M. Deal, Kirsten A. Nyrop, Matthew I. Milowsky, Hyman B. Muss, Angela B. Smith +1 more

The association between functional impairment pre- and post-cystectomy with neoadjuvant chemotherapy use in patients with muscle-invasive bladder cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17008

N/A

0DataRank · unranked

0 citations

Allison M. Deal, Kirsten A. Nyrop, Matthew I. Milowsky, Hyman B. Muss, Angela B. Smith +1 more

Matthew I. Milowsky

Indexed papers

Top data-sharing exemplar

Papers